PROTOCOL,PUB_ID,RX_CODE,RX_LABEL,AGE,SEX,RACE,HISPANIC,DISC_FL,DISC_RSN,DISC_RSN_O,EARLY_TERM_FL,TERM_RSN,TERM_AE,NUM_VAC_RECD
108,108-003,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",22,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-004,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",19,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-009,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",29,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-010,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",19,Female,White,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,1
108,108-011,T7,"Protein/AS01B mo(0,1,6)",24,Male,Asian,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,2
108,108-013,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",23,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-014,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",22,Male,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-017,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",21,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-018,P1,"Placebo mo(0,1,3,6)",29,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-019,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",40,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-022,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",26,Male,White,No,,,,Yes,Unable to contact participant,No,3
108,108-023,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",27,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-024,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",33,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-026,P1,"Placebo mo(0,1,3,6)",20,Female,Black,No,Yes,Refused,,Yes,Participant refused further participatio,No,1
108,108-029,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",20,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-030,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",20,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-031,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",35,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-032,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",23,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-034,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",29,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-036,T7,"Protein/AS01B mo(0,1,6)",28,Male,Other,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-037,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",30,Female,White,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,2
108,108-038,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",20,Female,Black,No,,,,Yes,HIV infection,No,4
108,108-039,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",22,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-041,P1,"Placebo mo(0,1,3,6)",25,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-042,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",23,Male,White,No,Yes,Other clinical event,,No,Scheduled exit visit/end of study,No,1
108,108-043,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",40,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-046,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-047,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",26,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-050,T7,"Protein/AS01B mo(0,1,6)",24,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-052,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",19,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-053,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",18,Female,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-055,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",33,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-056,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",24,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-057,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",32,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-059,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",18,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-060,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",34,Male,Other,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-061,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",30,Female,Black,No,,,,Yes,Unable to contact participant,No,4
108,108-062,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",29,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-064,T7,"Protein/AS01B mo(0,1,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-065,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",26,Female,White,No,,,,Yes,Unable to contact participant,No,4
108,108-066,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",36,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-067,T7,"Protein/AS01B mo(0,1,6)",24,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-068,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",31,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-069,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-070,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",30,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-071,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-072,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",22,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-073,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",29,Female,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-075,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Male,White,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,2
108,108-076,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",19,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-077,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",24,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-078,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",36,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-079,T7,"Protein/AS01B mo(0,1,6)",19,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-080,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",25,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-084,T7,"Protein/AS01B mo(0,1,6)",22,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-087,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",31,Female,White,Yes,Yes,Other,PSRT recommendation based on pre-existing condition of optic neuropathy.,Yes,Unable to contact participant,No,1
108,108-090,T7,"Protein/AS01B mo(0,1,6)",25,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-091,T7,"Protein/AS01B mo(0,1,6)",22,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-095,P1,"Placebo mo(0,1,3,6)",21,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-096,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",30,Female,Black,Yes,Yes,Pregnancy,,No,Scheduled exit visit/end of study,No,3
108,108-097,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",33,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-099,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",25,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-100,T7,"Protein/AS01B mo(0,1,6)",33,Female,Black,No,Yes,Refused,,Yes,Participant refused further participatio,No,3
108,108-104,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",20,Male,Asian,No,,,,Yes,Unable to contact participant,No,4
108,108-106,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",28,Female,Black,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-107,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",28,Female,Black,No,Yes,Other,PPT terminated from the study,Yes,Participant refused further participatio,No,3
108,108-108,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",19,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-109,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",21,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-110,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",29,Male,White,No,,,,Yes,Unable to contact participant,No,4
108,108-111,P1,"Placebo mo(0,1,3,6)",21,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-113,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",22,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-114,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",24,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-118,T7,"Protein/AS01B mo(0,1,6)",20,Male,Other,Yes,,,,Yes,Unable to contact participant,No,4
108,108-120,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",32,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-121,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",22,Female,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-122,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-123,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",22,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-124,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",22,Male,Black,No,,,,Yes,Participant refused further participatio,No,3
108,108-125,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",20,Male,White,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-126,P1,"Placebo mo(0,1,3,6)",38,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-128,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-129,T7,"Protein/AS01B mo(0,1,6)",36,Male,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-131,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-136,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",18,Male,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-137,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",22,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-138,T7,"Protein/AS01B mo(0,1,6)",25,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-141,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",38,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-142,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",23,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-143,T7,"Protein/AS01B mo(0,1,6)",30,Male,Other,Yes,,,,Yes,Unable to contact participant,No,4
108,108-146,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",39,Female,Black,No,Yes,HIV infection,,Yes,HIV infection,No,3
108,108-148,P1,"Placebo mo(0,1,3,6)",22,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-149,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-150,P1,"Placebo mo(0,1,3,6)",23,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-152,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Male,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-154,T7,"Protein/AS01B mo(0,1,6)",25,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-155,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",24,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-156,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-158,P1,"Placebo mo(0,1,3,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-160,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",29,Male,White,No,,,,Yes,Unable to contact participant,No,2
108,108-161,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",30,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-163,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",18,Female,Multiracial,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-166,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",21,Female,Black,No,,,,Yes,Unable to contact participant,No,4
108,108-170,T7,"Protein/AS01B mo(0,1,6)",25,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-171,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",21,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-174,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",28,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-175,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",34,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-177,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",22,Male,Black,No,Yes,Refused,,Yes,"Other, specify",No,1
108,108-178,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",22,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-180,T7,"Protein/AS01B mo(0,1,6)",28,Male,Black,No,,,,Yes,Unable to contact participant,No,4
108,108-184,T7,"Protein/AS01B mo(0,1,6)",39,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-186,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",23,Male,Multiracial,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-187,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",21,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-190,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",29,Female,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-191,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",28,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-193,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",26,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-196,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",21,Male,Other,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-200,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",25,Male,Native American/Alaskan Native,No,,,,Yes,Unable to contact participant,No,4
108,108-201,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",36,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-204,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-206,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",30,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-207,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",20,Female,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-208,T7,"Protein/AS01B mo(0,1,6)",34,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-209,P1,"Placebo mo(0,1,3,6)",36,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-210,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",20,Female,Black,No,,,,Yes,HIV infection,No,4
108,108-212,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-213,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",37,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-214,T7,"Protein/AS01B mo(0,1,6)",22,Female,White,No,,,,Yes,Unable to contact participant,No,3
108,108-215,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",28,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-217,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",28,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-219,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",22,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-220,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",30,Female,Black,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-222,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",22,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-225,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-227,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",24,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-228,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",24,Male,Black,No,,,,Yes,"Investigator decision, specify",No,1
108,108-229,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",20,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-230,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",21,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-231,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",18,Male,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-233,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-234,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-236,P1,"Placebo mo(0,1,3,6)",33,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-238,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",38,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-240,T7,"Protein/AS01B mo(0,1,6)",25,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-242,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",20,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-245,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",21,Female,Black,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-247,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",24,Female,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-248,P1,"Placebo mo(0,1,3,6)",22,Female,White,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-249,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-250,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",29,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-251,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",30,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-253,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",28,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-254,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",38,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-257,T7,"Protein/AS01B mo(0,1,6)",26,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-259,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",28,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-260,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",28,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-262,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",22,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-263,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",24,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-264,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",22,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-265,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",32,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-267,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",20,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-269,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",21,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-271,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",29,Male,Black,No,,,,Yes,Unable to contact participant,No,4
108,108-272,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",19,Female,White,No,,,,Yes,Unable to contact participant,No,3
108,108-274,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",23,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-276,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",22,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-277,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-279,P1,"Placebo mo(0,1,3,6)",28,Female,White,No,Yes,Other,The ppt's new job schedule does not allow her the flexibility to continue study participation.,Yes,Participant unable to adhere to visit sc,No,2
108,108-281,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",23,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-282,T7,"Protein/AS01B mo(0,1,6)",22,Female,White,No,,,,No,Scheduled exit visit/end of study,No,2
108,108-283,T7,"Protein/AS01B mo(0,1,6)",23,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-285,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-286,T7,"Protein/AS01B mo(0,1,6)",25,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-287,T7,"Protein/AS01B mo(0,1,6)",30,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-289,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",26,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-290,T7,"Protein/AS01B mo(0,1,6)",21,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-292,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",28,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-295,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",39,Female,White,Yes,,,,No,Scheduled exit visit/end of study,No,3
108,108-296,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",23,Female,Black,No,,,,Yes,Unable to contact participant,No,4
108,108-297,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",28,Male,White,No,Yes,Other,NP Tappin determined that the ppt's risk status has changed; he is no longer a low-risk subject.,No,Scheduled exit visit/end of study,No,3
108,108-299,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",24,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-300,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",36,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-301,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",28,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-302,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",33,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-303,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",22,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-304,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",29,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-305,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",26,Female,White,No,Yes,Refused,,Yes,Participant refused further participatio,No,2
108,108-306,T7,"Protein/AS01B mo(0,1,6)",22,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-308,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",32,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-309,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Male,White,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-310,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-312,T7,"Protein/AS01B mo(0,1,6)",30,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-313,P1,"Placebo mo(0,1,3,6)",37,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-317,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",18,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-318,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",20,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-320,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",23,Male,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-321,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",21,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-322,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",18,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-323,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",24,Female,Other,No,,,,Yes,Unable to contact participant,No,2
108,108-324,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",19,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-325,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",23,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-326,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",24,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-327,T7,"Protein/AS01B mo(0,1,6)",25,Male,Asian,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,3
108,108-329,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",25,Male,Black,No,,,,Yes,Unable to contact participant,No,4
108,108-330,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",29,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-331,T7,"Protein/AS01B mo(0,1,6)",24,Female,Multiracial,No,Yes,Reactogenicity symptom,,Yes,"Other, specify",No,2
108,108-332,T7,"Protein/AS01B mo(0,1,6)",24,Male,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-333,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",28,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-335,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",24,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-336,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Female,Black,No,Yes,Participant relocated,,Yes,"Investigator decision, specify",No,2
108,108-337,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",23,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-338,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",22,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-339,T7,"Protein/AS01B mo(0,1,6)",23,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-340,P1,"Placebo mo(0,1,3,6)",19,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-341,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",38,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-342,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",23,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-347,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",28,Male,Black,No,Yes,Refused,,Yes,Participant refused further participatio,No,1
108,108-349,P1,"Placebo mo(0,1,3,6)",39,Female,Black,No,Yes,Other,Hypertension not well controlled.,No,Scheduled exit visit/end of study,No,1
108,108-351,P1,"Placebo mo(0,1,3,6)",27,Male,White,No,,,,Yes,Unable to contact participant,No,3
108,108-353,T7,"Protein/AS01B mo(0,1,6)",36,Male,Black,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,1
108,108-354,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-357,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",38,Female,White,No,,,,Yes,Unable to contact participant,No,4
108,108-358,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-359,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",21,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-360,T7,"Protein/AS01B mo(0,1,6)",29,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-361,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",25,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-363,T7,"Protein/AS01B mo(0,1,6)",19,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-365,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",25,Female,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-368,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",23,Female,Asian,No,,,,Yes,Unable to contact participant,No,2
108,108-369,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",20,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-373,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",26,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-374,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",21,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-376,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",28,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-378,P1,"Placebo mo(0,1,3,6)",21,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-380,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",22,Female,White,No,Yes,Other,present schedule does not allow time for study visits,No,Scheduled exit visit/end of study,No,2
108,108-381,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",23,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-382,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",23,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-383,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",24,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-385,T7,"Protein/AS01B mo(0,1,6)",19,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-386,T7,"Protein/AS01B mo(0,1,6)",27,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-387,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",30,Female,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-388,P1,"Placebo mo(0,1,3,6)",29,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-389,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",35,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-391,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-392,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",21,Female,White,No,,,,Yes,Unable to contact participant,No,4
108,108-393,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",23,Male,Black,No,,,,Yes,Participant refused further participatio,No,3
108,108-395,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",23,Female,Black,No,,,,Yes,HIV infection,No,4
108,108-396,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",23,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-397,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",21,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-398,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",20,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-399,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",26,Female,Asian,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,2
108,108-400,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",26,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-401,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-405,P1,"Placebo mo(0,1,3,6)",27,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-407,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",23,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-408,P1,"Placebo mo(0,1,3,6)",22,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-410,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",23,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-412,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",21,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-413,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",18,Male,Asian,No,,,,Yes,Unable to contact participant,No,4
108,108-415,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",24,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-416,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",28,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-418,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",28,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-419,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",18,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-420,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",29,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-423,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",34,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-425,T7,"Protein/AS01B mo(0,1,6)",27,Male,Black,No,,,,Yes,Unable to contact participant,No,3
108,108-426,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-428,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",25,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-429,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",18,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-430,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",25,Female,Black,No,Yes,Other,"Participant relocated to Giyani, she's no longer interested.",Yes,"Participant relocated, no follow-up plan",No,1
108,108-436,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",32,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-437,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",23,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-440,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",24,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-442,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",20,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-443,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",18,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-445,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",33,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-447,T7,"Protein/AS01B mo(0,1,6)",23,Female,White,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,2
108,108-448,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",29,Female,White,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-450,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",23,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-452,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",30,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-453,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",21,Female,Black,Yes,,,,Yes,Unable to contact participant,No,4
108,108-455,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",35,Female,Other,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-456,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",29,Female,Other,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-457,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",32,Male,Other,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-458,T7,"Protein/AS01B mo(0,1,6)",26,Female,White,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,2
108,108-459,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",29,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-460,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",28,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-461,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",24,Female,White,No,,,,Yes,Unable to contact participant,No,2
108,108-463,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",29,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-464,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",29,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-466,T7,"Protein/AS01B mo(0,1,6)",38,Male,Black,No,,,,Yes,Unable to contact participant,No,4
108,108-467,T7,"Protein/AS01B mo(0,1,6)",18,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-468,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",34,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-469,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",25,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-470,P1,"Placebo mo(0,1,3,6)",20,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-474,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Female,White,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,2
108,108-476,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",23,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-477,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",20,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-478,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",25,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-480,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",19,Female,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-481,T7,"Protein/AS01B mo(0,1,6)",23,Female,Black,No,,,,Yes,"Investigator decision, specify",No,3
108,108-484,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",37,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-485,T7,"Protein/AS01B mo(0,1,6)",23,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-486,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",19,Female,White,Yes,,,,Yes,Unable to contact participant,No,1
108,108-489,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",18,Female,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-490,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",23,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-491,P1,"Placebo mo(0,1,3,6)",25,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-492,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",20,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-493,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",24,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-494,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",21,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-495,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",33,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-496,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",25,Female,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-497,P1,"Placebo mo(0,1,3,6)",28,Male,Black,No,,,,Yes,Unable to contact participant,No,4
108,108-499,T7,"Protein/AS01B mo(0,1,6)",33,Female,White,No,,,,Yes,Unable to contact participant,No,4
108,108-501,T7,"Protein/AS01B mo(0,1,6)",18,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-502,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",20,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-503,T3,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",31,Male,Other,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-504,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",22,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-505,T7,"Protein/AS01B mo(0,1,6)",19,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-506,T7,"Protein/AS01B mo(0,1,6)",27,Male,White,No,,,,Yes,Unable to contact participant,No,4
108,108-507,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",31,Female,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-509,T4,"DNA mo(0,1,6) + Protein/MF59 mo(0,1,6)",25,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-511,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",27,Female,Multiracial,Yes,,,,No,Scheduled exit visit/end of study,No,4
108,108-512,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-513,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",31,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-514,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",30,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-515,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",25,Female,White,Yes,Yes,Pregnancy,,No,Scheduled exit visit/end of study,No,3
108,108-516,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",30,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-517,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",30,Male,White,No,,,,No,Scheduled exit visit/end of study,No,3
108,108-518,T5,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",27,Female,White,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,2
108,108-519,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",22,Female,Black,No,Yes,Other,ppt started a new job and was unable t continue with tthe study,Yes,Participant refused further participatio,No,1
108,108-520,T1,"DNA mo(0,1,3,6) + Protein/MF59 mo(3,6)",19,Female,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-522,T7,"Protein/AS01B mo(0,1,6)",21,Male,Black,No,,,,Yes,"Investigator decision, specify",No,1
108,108-523,T2,"DNA mo(0,1,3,6) + Protein/AS01B mo(3,6)",26,Male,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
108,108-524,T6,"DNA mo(0,1,6) + Protein/AS01B mo(0,1,6)",31,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4